High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children

Bone Marrow Transplantation

Volumn 36, Issue 2, 2005, Pages 135-138

  Ratjen, F ^a   Rjabko, O ^a   Kremens, B ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Anti inflammatory treatment; Bronchiolitis obliterans; Children

Indexed keywords

AZITHROMYCIN; BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYGEN; PREDNISONE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BRONCHIOLITIS OBLITERANS; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG PULSE THERAPY; EXPERIENCE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; LUNG FUNCTION; MALE; MEDICAL DECISION MAKING; NONHODGKIN LYMPHOMA; OXYGEN SATURATION; PRIORITY JOURNAL; PUVA; RESPIRATORY FAILURE; SHWACHMAN SYNDROME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; HEMATOLOGIC DISEASES; HUMANS; INFANT; MALE; METHYLPREDNISOLONE; TRANSPLANTATION, HOMOLOGOUS;

EID: 22744435420     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705026     Document Type: Article

References (27)

1. Palmas A, Tefferi A, Myers JL et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100: 680-687.
2. Duncker C, Dohr D, Harsdorf S et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000; 25: 1263-1268.
3. Griese M, Rampf U, Hofmann D et al. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30: 393-401.
4. Patriarca F, Skert C, Sperotto A et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004; 33: 751-758.
5. Ostrow D, Buskard N, Hill RS et al. Bronchiolitis obliterans complicating bone marrow transplantation. Chest 1985; 87: 828-830.
6. Clark JG, Crawford SW, Madtes DK et al. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368-376.
7. Schwarer AP, Hughes JM, Trotman-Dickenson B et al. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992; 54: 1002-1008.
8. Schultz KR, Green GJ, Wensley D et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994; 84: 3212-3220.
9. Philit F, Wiesendanger T, Archimbaud E et al. Post-transplant obstructive lung disease ('bronchiolitis obliterans'): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995; 8: 551-558.
10. Trisolini R, Bandini G, Stanzani M et al. Morphologic changes leading to bronchiolitis obliterans in a patient with delayed non-infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 1167-1170.
11. Jaramillo A, Fernandez FG, Kuo EY et al. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 2005; 9: 84-93.
12. Cooper JD, Billingham M, Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allograft. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12: 713-716.
13. Rajagopalan N, Maurer J, Kesten S. Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients. Chest 1996; 109: 405-407.
14. Marras TK, Szalai JP, Chan CK et al. Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument. Bone Marrow Transplant 2002; 30: 599-607.
15. Marras TK, Chan CK, Lipton JH et al. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004; 33: 509-517.
16. Worthy SA, Flint JD, Muller NL. Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings. Radiographics 1997; 17: 1359-1371.
17. Ooi GC, Peh WC, Ip M. High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation. Respiration 1998; 65: 187-191.
18. Jung JI, Jung WS, Hahn ST et al. Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings. Korean J Radiol 2004; 5: 107-113.
19. Dudek AZ, Mahaseth H, DeFor TE et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657-666.
20. Fleisher GR, Ludwig S (eds). Textbook of Pediatric Emergency Medicine, 3rd edn. Williams and Wilkins: Baltimore, MD, 1993.
21. Rabitsch W, Deviatko E, Keil F et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation 2001; 71: 1341-1343.
22. Clement A. ERS Task Force. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004; 24: 686-697.
23. Kudoh S. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases. Am J Med 2004; 117: 12S-19S.
24. Gerhardt SG, McDyer JF, Girgis RE et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003; 168: 121-125.
25. Ishii T, Manabe A, Ebihara Y et al. Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin. Bone Marrow Transplant 2000; 26: 907-910.
26. Siddiqui J. Immunomodulatory effects of macrolides: implications for practicing clinicians. Am J Med 2004; 117: 26S-29S.
27. Blanco D. Breathing new life into home care. Texas hospital remotely monitors the pulmonary function of post-transplant pediatric patients. Health Manag Technol 2004; 25: 38-40.